Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Petmed Express Inc (NASDAQ:PETS)

44.01
Delayed Data
As of Dec 14
 -1.04 / -2.31%
Today’s Change
19.21
Today|||52-Week Range
50.90
+90.77%
Year-to-Date
SECTOR
Retail Trade
INDUSTRY
Drugstore Chains
MARKET CAP
$928.2M

Company Description

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins and nutritional supplements, and hygiene products; and it also offers prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, antibiotics and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail/print advertising campaigns. The company's products include a majority of brands of medication such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. Petmed Express was founded in January 1996 and is headquartered in Pompano Beach, FL.

Contact Information

PetMed Express, Inc.
420 South Congress Avenue
Delray Beach Florida 33445
P:(561) 526-4444
Investor Relations:
195497959958600

Employees

Shareholders

Other institutional63.17%
Mutual fund holders37.60%
Individual stakeholders24.45%

Top Executives

Menderes AkdagPresident, Chief Executive Officer & Director
Bruce S. RosenbloomTreasurer, Chief Financial & Accounting Officer .l
Alison BergesSecretary & General Counsel